Figure 2 | Scientific Reports

Figure 2

From: Validation of a CE-IVD, urine exosomal RNA expression assay for risk assessment of prostate cancer prior to biopsy

Figure 2

Receiver-Operating-Characteristics Curve and Decision Curve/Net Benefit analysis of EPI-CE compared to PSA and the two multiparametric risk calculators, PCPT and ERSPC, showing that the EPI-CE score provides a higher Area-Under-Curve (AUC) and a higher Net Benefit than either of the multivariate risk calculators across a wide range of risk acceptance levels.

Back to article page